APA
Tammela T. L., Häggman M., Ladjevardi S., Taari K., Isotalo T., Lennernäs H., Weis J., von Below C., Wassberg C., Lennernäs B., Tolf A., Axén N., Gölander C. & Ahlström H. (20190424). An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer. : The Journal of urology.
Chicago
Tammela Teuvo L, Häggman Michael, Ladjevardi Sam, Taari Kimmo, Isotalo Taina, Lennernäs Hans, Weis Jan, von Below Catrin, Wassberg Cecilia, Lennernäs Bo, Tolf Anna, Axén Niklas, Gölander Carl-Gustaf and Ahlström Håkan. 20190424. An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer. : The Journal of urology.
Harvard
Tammela T. L., Häggman M., Ladjevardi S., Taari K., Isotalo T., Lennernäs H., Weis J., von Below C., Wassberg C., Lennernäs B., Tolf A., Axén N., Gölander C. and Ahlström H. (20190424). An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer. : The Journal of urology.
MLA
Tammela Teuvo L, Häggman Michael, Ladjevardi Sam, Taari Kimmo, Isotalo Taina, Lennernäs Hans, Weis Jan, von Below Catrin, Wassberg Cecilia, Lennernäs Bo, Tolf Anna, Axén Niklas, Gölander Carl-Gustaf and Ahlström Håkan. An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer. : The Journal of urology. 20190424.